Literature DB >> 624152

Recurrent sustained ventricular tachycardia. 1. Mechanisms.

M E Josephson, L N Horowitz, A Farshidi, J A Kastor.   

Abstract

The mechanism of recurrent sustained ventricular tachycardia (VT) was evaluated in 21 patients. Re-entry as the mechanism for VT was suggested by a) the reproducible initiation (19) and termination (15) of the arrhythmia by programmed stimulation. The rate, ventricle of origin, and stimulation site determined the method of termination. One VPD was usually required with VT rates less than 175/min and/or ventricle of origin ipsilateral to the stimulation site, while two VPDs were usually required for VT with faster rates originating in a contralateral ventricle. The proximal His-Purkinje system (HPS) was not required for initiation or maintenance of VT. Evidence localizing the site of re-entry to a small portion of the ventricles included: a) ventricular capture by ventricular premature depolarizations (VPDs) or pacing (VP) without terminating VT (5), b) sinus capture following VPDs and/or supraventricular fusions without terminating VT (12), and c) atrial pacing normalizing the QRS and H-V intervals without terminating VT (5).

Entities:  

Mesh:

Year:  1978        PMID: 624152     DOI: 10.1161/01.cir.57.3.431

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  35 in total

Review 1.  Mechanisms of monomorphic ventricular tachycardia in coronary artery disease.

Authors:  Ralph Lazzara; Benjamin J Scherlag
Journal:  J Interv Card Electrophysiol       Date:  2003-04       Impact factor: 1.900

Review 2.  Amiodarone: maximising survival benefit with empiric or guided therapy.

Authors:  G Steinbeck; U Dorwarth; E Hoffmann
Journal:  J Interv Card Electrophysiol       Date:  2000-01       Impact factor: 1.900

3.  2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.

Authors:  Edmond M Cronin; Frank M Bogun; Philippe Maury; Petr Peichl; Minglong Chen; Narayanan Namboodiri; Luis Aguinaga; Luiz Roberto Leite; Sana M Al-Khatib; Elad Anter; Antonio Berruezo; David J Callans; Mina K Chung; Phillip Cuculich; Andre d'Avila; Barbara J Deal; Paolo Della Bella; Thomas Deneke; Timm-Michael Dickfeld; Claudio Hadid; Haris M Haqqani; G Neal Kay; Rakesh Latchamsetty; Francis Marchlinski; John M Miller; Akihiko Nogami; Akash R Patel; Rajeev Kumar Pathak; Luis C Saenz Morales; Pasquale Santangeli; John L Sapp; Andrea Sarkozy; Kyoko Soejima; William G Stevenson; Usha B Tedrow; Wendy S Tzou; Niraj Varma; Katja Zeppenfeld
Journal:  J Interv Card Electrophysiol       Date:  2020-10       Impact factor: 1.900

Review 4.  Clinical and interventional electrophysiology: a personal historical perspective.

Authors:  B Lüderitz
Journal:  J Interv Card Electrophysiol       Date:  1997-11       Impact factor: 1.900

5.  Effects of the myocardial-selective alpha 1-adrenoceptor antagonist UK-52046 and atenolol, alone and in combination, on experimental cardiac arrhythmias in dogs.

Authors:  A G Uprichard; D W Harron; R Wilson; R G Shanks
Journal:  Br J Pharmacol       Date:  1988-12       Impact factor: 8.739

6.  Mark E Josephson: Clinical Investigator.

Authors:  John M Miller
Journal:  Arrhythm Electrophysiol Rev       Date:  2017-04

7.  Modulation of conduction and refractoriness in atrioventricular junctional reentrant circuit. Effect on reentry initiated by atrial extrastimulus.

Authors:  R Mahmud; S T Denker; P J Tchou; M Jazayeri; M Akhtar
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

Review 8.  Evaluation and treatment strategies in patients at high risk of sudden death post myocardial infarction.

Authors:  R D Underwood; J Sra; M Akhtar
Journal:  Clin Cardiol       Date:  1997-09       Impact factor: 2.882

Review 9.  Can the technicalities of electrophysiological testing for ventricular tachycardia be simplified?

Authors:  D E Ward
Journal:  Br Heart J       Date:  1987-11

Review 10.  Mechanisms of sudden cardiac death.

Authors:  Samuel K McElwee; Alejandro Velasco; Harish Doppalapudi
Journal:  J Nucl Cardiol       Date:  2016-07-25       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.